Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy-Reference-Cited by-同舟云学术

Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy

Published:2006-08 Issue:944 Volume:79 Page:e53-e58
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Basu S,Nair N

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://www.birpublications.org/doi/pdf/10.1259/bjr/27645093

Reference14 articles.

1. Shulkin BL, Shapiro B, Hutchinson RJ. I-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.J Nucl Med1992;33:1735–40.

2. Gordon I, Peters AM, Gutman A, et al. Skeletal assessment in neuroblastoma- the pitfalls of iodine-123-MIBG scan.J Nucl Med1990;31:129–34.

3. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology

4. MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION

5. SUCCESSFUL OUTCOMES IN PHEOCHROMOCYTOMA SURGERY IN THE MODERN ERA

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐risk abdominal pediatric paraganglioma;Pediatric Blood & Cancer;2022-08-15

2. Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT;Indian Journal of Medical and Paediatric Oncology;2022-02-02

3. The current place and indications of 131I-metaiodobenzylguanidine therapy in the era of peptide receptor radionuclide therapy;Nuclear Medicine Communications;2015-01

4. Dose fractionation in 131I-metaiodobenzylguanidine (MIBG) therapy: should the tumour biology and intent of therapy be the guide?;European Journal of Nuclear Medicine and Molecular Imaging;2010-07-02

5. Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy;Annals of Nuclear Medicine;2007-07-25